Most lately, it's been identified that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in identical parts as classical opioid receptors, it binds into a big selection of endogenous opioids. In contrast to most opioid receptors, this receptor acts like a scavenger https://henryu194iwq5.bloggazzo.com/profile